Galena Biopharma, Inc. (GALE)

Trade GALE now with
12/29/2017 9:26:34 AM Galena Biopharma Stockholders Approve Business Combination With SELLAS Life Sciences Group
10/2/2017 7:37:46 AM SELLAS Enters Into Clinical Trial Collaboration And Supply Agreement With Merck
9/28/2017 7:07:29 AM Galena Biopharma Says Completes Enrollment In Two NeuVax Clinical Trials In Combination With Trastuzumab
9/11/2017 7:06:27 AM Galena Biopharma And BioVascular Reaffirm GALE-401 Partnership
4/4/2017 7:06:17 AM Galena Biopharma Presents Positive Interim Safety Data On NeuVax Clinical Trial In Combination With Trastuzumab
3/17/2017 7:05:45 AM Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data
2/21/2017 4:14:41 PM Galena Biopharma Appoints Stephen Ghiglieri As Interim CEO
2/8/2017 8:34:09 AM Galena Biopharma Prices Public Offering Of Units With Anticipated Gross Proceeds Of $17 Mln
2/6/2017 7:06:16 AM Galena Reports Positive Outcome From DSMB On Two NeuVax Trials In Combination With Trastuzumab
12/28/2016 7:10:11 AM Galena Biopharma Confirms Regulatory Pathway To Advance GALE-401 (Anagrelide Controlled Release) Into Phase 3 Trial
12/14/2016 7:07:00 AM Galena Biopharma Announces Phase 2 Trial Of NeuVax In DCIS Open For Enrollment And Screening Patients
11/14/2016 7:06:29 AM Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data At Society For Immunotherapy Of Cancer Conference 2016